IL13 and Increased total eosinophil count: In addition, substantial evidence exists from in vitro cell culture models, in vivo animal models and observational human studies for the role of IL-13 (and IL-4) in driving eosinophilia and type 2 inflammation, which led to interventional studies targeting these pathways in human disease.